Abstract:Reactive oxygen species (ROS) attract increasing interests due to the function of "double-edged sword" in physiological condition. In low concentration, ROS can benefit the growth of normal cells; however, in high concentration, they will induce cell apoptosis. Selenium is an essential trace element of human beings that can regulate the concentration of ROS. Previous work demonstrated the selective anti-cancer activity of coordinating assemblies consisting of selenium-containing amphiphile (EGSe) and cisplatin, but the structure and mechanism remain unclear. We synthesized another selenium-containing amphiphile-trimethyl-EGSe (EGSe-tMe) which has similar structure with EGSe but forms weaker interaction with platinum-containing compounds. Then, we prepared new coordinating assemblies composed of two types of selenium-containing amphiphiles and two types of platinum-containing compounds (cisplatin, platinum dichloride), in order to study the coordinating interaction between selenium and platinum. Additionally, we studied the mechanism of their selective anti-cancer activity by testing the ability of regulating ROS concentration in cancer cells and normal cells. We found that EGSe could coordinate with both cisplatin and platinum dichloride, resulting in the formation of coordinating assemblies with selective anti-cancer activity. However, coordinating assemblies consisting of EGSe-tMe and platinum-containing compounds showed little selectivity. These results indicate the important role of tight interaction between selenium and platinum played in the selective anti-cancer activity. The anti-cancer activity comes from their function of regulating the concentration of ROS in cells. Selenium-containing coordinating assemblies can raise higher concentration of ROS in cancer cells than in normal cells, thus causing selective toxicity to cancer cells. In further study, we proposed the mechanism of ROS production by selenium-containing coordinating assemblies. The coordinating assemblies can induce ROS production with the proof of electron spin resonance (ESR) measurement. We hope that this work can not only broaden the applications of selenium-containing coordinating assemblies in the field of cancer treatment, but also provide a new route for developing selective anti-cancer drugs.

Anticancer Effect and Mechanism of a Se-modified Porphyrin Au(III) Complex

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Triphenylamine-substituted Zinc Porphyrin Nanoparticles with Photodynamic/photothermal Activity for Cancer Phototherapy in Vitro

Photothermal conversion-coordinated Fenton-like and photocatalytic reactions of Cu 2-x Se-Au Janus nanoparticles for tri-combination antitumor therapy.

Nanomedicine Assembled by Coordinated Selenium-Platinum Complexes Can Selectively Induce Cytotoxicity in Cancer Cells by Targeting the Glutathione Antioxidant Defense System

Photothermal conversion-coordinated Fenton-like and photocatalytic reactions of Cu2-xSe-Au Janus nanoparticles for tri-combination antitumor therapy

Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing GPX4-mediated ferroptosis

Anticancer Mechanism of Novel Metal Drugs with Different Metal Centers

Lysosomal Targeted Cyclometallic Iridium(III) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application

Supramolecular palladium complexes based on guanidinium pillar[5]arene for cancer therapy

Selenium-platinum coordination compounds as novel anticancer drugs: selectively killing cancer cells via a reactive oxygen species (ROS)-mediated apoptosis route.

Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

Isosteric Replacement of Sulfur to Selenium in a Thiosemicarbazone: Promotion of Zn(II) Complex Dissociation and Transmetalation to Augment Anticancer Efficacy

A Green Synthesis of Au-Ag Alloy Nanoparticles using Polydopamine Chemistry: Evaluation of their Anticancer Potency Towards Both MCF-7 Cells and their Cancer Stem Cells Subgroup

Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes

Quantum chemical studies of the electronic structures of anti-tumor agents: Au<SUP>III</SUP>L+ (L = porphine, tetraphenylporphyrin)

Selenium-containing Coordinating Assemblies with Selective Anti-cancer Activity: the Control of Reactive Oxygen Species

Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models

Applying Cu(II) complexes assisted by water‐soluble porphyrin to DNA binding and selective anticancer activities